What Transformation Has the Heart Blocks Treatment Devices Market Undergone?
The heart blocks treatment devices market has seen considerable growth due to a variety of factors.
•The market size for devices used in the treatment of heart blockages has experienced robust growth recently. The projections show an increase from $3.22 billion in 2024 to $3.38 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.0%.
Several factors contributed to this historic growth, including advancements in implantable cardioverter defibrillators (icds), the development of cardiac resynchronization therapy (crt), miniaturization and leadless devices, clinical trials backed by evidence-based medicine, guidelines and recommendations, and an increase in cardiovascular disease cases.
How Will The Heart Blocks Treatment Devices Market Size Evolve In The Foreseeable Future?
The heart blocks treatment devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for devices used in treating heart blocks is forecasted to witness robust growth in the upcoming years. It is projected to escalate to $4.4 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.8%.
Multiple factors could be responsible for the growth in the predicted period, including advancements in wireless connectivity and remote monitoring, spread of wearable cardioverter defibrillators (WCDs), customised treatment algorithms, and enhanced patient-focused design and comfort. A significant increase in the adoption of MRI-compatible devices will also contribute to this growth. Key tendencies during the forecast period will involve the escalating integration of telemedicine platforms, remote programming and updates, maintenance supported by AI, focused attention on user experience, and the growing scope of home-based care.
What Are The Essential Drivers Behind The Growth Of The Heart Blocks Treatment Devices Market?
The escalating occurrence of cardiovascular disease is anticipated to fuel the expansion of the heart blocks treatment devices market in the future. Circulatory system ailments, which impact the heart and blood vessels, include conditions like coronary artery disease, heart failure, and stroke. The swift surge in cardiovascular disease is chiefly propelled by an aging population, changes in lifestyle and diet, and rising instances of obesity and diabetes. Heart blocks treatment devices are employed to manage cardiovascular disorders by rectifying abnormalities or defects in the heart's structures and blocks. For example, in March 2024, as per the data provided by GOV.UK, a UK-based governmental services and information provider, in the fiscal year that ended in 2023, slightly above 1,862,500 citizens in England, which constitutes 3% of the population, carried a GP diagnosis of coronary heart disease (CHD). Therefore, the escalating prevalence of cardiovascular disease is spurring the expansion of the heart blocks treatment devices market.
How Is The Global Heart Blocks Treatment Devices Market Divided Into Key Segments?
The heart blocks treatment devices market covered in this report is segmented –
1) By Type: First-Degree Heart Block, Second-Degree Heart Block, Third-Degree Heart Block
2) By Product: Transcutaneous Pacing (TCP), Pacemaker, Mediation, Follow-Up Electrophysiology Study
3) By End-User: Hospital Testing, Home Treatment, Clinics, Other End-Users
Subsegments:
1) By First-Degree Heart Block: Monitoring Devices, Pacemakers
2) By Second-Degree Heart Block: Type I (Wenckebach) Management Devices, Type II Management Devices, Pacemakers
3) By Third-Degree Heart Block: Permanent Pacemakers, Implantable Cardioverter-Defibrillators (ICDs), Cardiac Resynchronization Therapy (CRT) Devices
Pre-Book The Heart Blocks Treatment Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Heart Blocks Treatment Devices Market?
Innovative technological developments are emerging as a key trend in the heart blocks treatment devices industry. To remain competitive, companies within this market are embracing novel technologies. An example of this is Medtronic, a US firm providing medical technology and services, that in January 2023 introduced the smallest pacemaker worldwide for treating heart block. Named Micra AV, it's a tiny, completely self-sustaining pacemaker using a minimally invasive technique to offer innovative pacing technology to patients with atrioventricular (AV) block. Remarkably, this pacemaker is the first that can identify atrial activity without using a lead or other accessory in the heart's upper chamber.
Who Are the Key Players in the Heart Blocks Treatment Devices Market?
Major companies operating in the heart blocks treatment devices market include:
• MicroPort Scientific Corporation
• GE HealthCare
• Abbott Laboratories
• Medtronic plc
• Koninklijke Philips N.V.
• Stryker Corporation
• Boston Scientific Corporation
• Nihon Kohden Corporation
• Lepu Medical Technology (Beijing) Co.
• Zoll Medical Corporation
• LivaNova PLC
• Abiomed Inc.
• Cardiac Dimensions
• EBR Systems Inc.
• Endotronix Inc.
• Calon Cardio
• CVRx Inc.
• BioVentrix Inc.
• CorWave SA
• Leviticus Cardio
• BiVACOR
• Biotronik SE and CO KG
• CorMatrix Cardiovascular
• Shree Pacetronix Ltd.
• Jarvik Heart Inc.
• Osypka Medical GmbH.
What are the Regional Insights into the Heart Blocks Treatment Devices Market?
North America was the largest region in the heart blocks treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart blocks treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
